These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 13453644)

  • 1. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
    COLWELL AR; COLWELL JA
    Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
    [No Abstract]   [Full Text] [Related]  

  • 2. BZ 55 and D 860 in the treatment of diabetes mellitus.
    SCHNEIDER T; POLITZER WM
    S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061
    [No Abstract]   [Full Text] [Related]  

  • 3. CARBUTAMIDE and tolbutamide in diabetes.
    S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101
    [No Abstract]   [Full Text] [Related]  

  • 4. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
    KRAHL ME; LUKENS FD; RICKETTS HT
    Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of action of the sulfonylureas in diabetes mellitus.
    LEVINE R; SOBEL GW
    Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
    [No Abstract]   [Full Text] [Related]  

  • 6. The hypoglucemic sulfonylurea drugs; an interim evaluation.
    STETTEN D
    Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment for diabetes with sulfamide hypoglycemic agents].
    DEUIL R
    Rev Prat; 1956 Dec; 6(33):3687-94. PubMed ID: 13408836
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
    COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
    [No Abstract]   [Full Text] [Related]  

  • 9. Observations in diabetic subjects treated with sulfonylurea compounds.
    BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
    Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
    [No Abstract]   [Full Text] [Related]  

  • 10. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
    DAVIDSON JW; UNGER RH
    J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of sulfonylurea drugs in hospitalized diabetic patients.
    RICKETTS HT; WILDBERGER HL
    J Am Med Assoc; 1956 Nov; 162(11):1045-9. PubMed ID: 13366706
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods of selection of diabetic patients sensitive to sulfonylurea compounds.
    DUNCAN GG; JOINER CL; LEE CT
    Metabolism; 1956 Nov; 5(6 Part 2):964-71. PubMed ID: 13378066
    [No Abstract]   [Full Text] [Related]  

  • 15. Observations with sulfonylureas in diabetes.
    BROWN FR; FRISKEY RW; KINSELL LW; MICHAELS GD
    Metabolism; 1956 Nov; 5(6 Part 2):864-7. PubMed ID: 13378055
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical studies on the hypoglycaemic action of the sulphonylureas.
    BUTTERFIELD WJ; CAMP JL; HARDWICK C; HOLLING HE
    Lancet; 1957 Apr; 272(6972):753-6. PubMed ID: 13417585
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress report of American Diabetes Association on orally effective hypoglycemic sulfonylureas.
    COLWELL AR; INGLE D; KRAHL ME; LEVINE R; RICKETTS HT
    J Am Med Assoc; 1956 Nov; 162(10):976-7. PubMed ID: 13366694
    [No Abstract]   [Full Text] [Related]  

  • 18. [Criteria for selection of diabetics to be treated with oral hypoglycemic drugs; test for sensitivity to sulfonylurea compounds].
    ARDUINO F
    Med Cir Farm; 1957 May; (253):187-98. PubMed ID: 13450825
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860)].
    BERTRAM F
    Gaz Med Fr; 1957 Mar; 64(6):519-24. PubMed ID: 13427958
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolbutamide in treatment of diabetes mellitus.
    BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE
    Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.